NOW vs ORCL: Which Is the Better Buy?

Side-by-side comparison of ServiceNow, Inc. and Oracle Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-18.
ServiceNow, Inc. Β· Technology
$103.24
+45.0% upside to fair value
Grade B High Quality
VS
Oracle Corporation Β· Technology
$184.31
+14.0% upside to fair value
Grade C High Quality
QuantHub Verdict
NOW has more upside to fair value (+45.0%). ORCL trades at a lower forward P/E (31.0x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric NOW ORCL
Current Price $103.24 $184.31
Fair Value Estimate $149.70 $210.13
Upside to Fair Value +45.0% +14.0%
Market Cap $106.5B $530.1B
Forward P/E 61.1x 31.0x
EV / EBITDA 32.9x 20.4x
Price / Sales 7.6x 7.9x
Price / FCF 23.0x -22.4x
Revenue Growth YoY +22.1% +20.6%
Gross Margin 76.6% 65.8%
Operating Margin 13.4% 30.8%
Return on Equity 15.0% 50.4%
Dividend Yield 0% 0%
FCF Yield 4.35% β€”
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
NOW β€” ServiceNow, Inc.
ServiceNow, Inc. operates in the technology sector specializing in software applications, delivering high-quality enterprise cloud solutions with a durable competitive moat evidenced by a 15% return on equity and strong gross margins of 76.6%. The company is currently in an investing growth phase with 22.1% revenue growth in the most recent quarter, although earnings growth is modest at 2.0%. Des…
ORCL β€” Oracle Corporation
Oracle Corporation is a leading enterprise software and cloud infrastructure provider with a durable competitive moat driven by its extensive software portfolio, strong cloud growth, and stable leadership. The company reported $57.4 billion in revenue for fiscal 2025, growing 8% year-over-year, with cloud services and license support growing 12%. Oracle's cloud infrastructure (OCI) is a key growt…
Accumulation Zones
Metric NOW ORCL
Zone Low $112.27 $157.60
Zone High $127.24 $178.61
In Buy Zone? Yes No
← NOW Research    ORCL Research β†’    All Research